LASR / RESEARCH · ↑ INDEX
2026-05-01
nLIGHT makes the high-energy fiber-laser modules that feed Iron Beam — Rafael's 100kW-class directed-energy interceptor that went operational in Israeli air-defense deployments in late 2025 — and it is the only Western supplier that fabricates its own semiconductor laser diodes, fiber lasers, beam combiners, and integrated weapon-grade systems under one roof. That vertical stack is what got nLIGHT into HELIOS Block 2, IFPC-HEL, and the JCO directed-energy programs while integrators who source diodes externally eat margin on every module. The moat compounds through qualification cycles that run 12-24 months per customer per diode and through a $162M funded backlog plus $184M of unfunded U.S. government contracts — roughly $346M of visibility against a ~$280M FY26 revenue base. The cutting/welding exit masks the A&D inflection: a -$25-30M revenue headwind will compress the FY26 headline print while A&D segment revenue grew ~50% YoY in 2025, which means the Street has to read past the sequential decline to see the acceleration. Six sessions from now, the Q1 print will confirm or break the book-to-bill walk — three consecutive quarters above 1.0x is the institutional bar for a defense-contractor inflection, and four quarters would lock it.
Portfolio Decision
Maintain LASR exposure at <= 1.5% NAV at $69.85
ahead of the 2026-05-07 Q1 2026 earnings release with a hard stop at
$63.43 (2026-04-29 intraday low). The setup is institutionally clean
but binary: A&D book-to-bill walked from 0.95x to 1.18x across 2025
and funded backlog grew 47% to $162M, but the equity is priced at 138x
forward earnings with $9.3M of insider distribution in the past 6
months and zero open-market buys. With 6 trading sessions to a
high-impact catalyst, the right call is to preserve optionality
without taking disproportionate event risk. Conditional upgrade to
Overweight (2.5% NAV) only on confirmed Q1 A&D segment revenue > $52M
AND funded backlog > $165M AND FY2026 guide reiterated as "total
revenue growth or better."
nLIGHT has spent 2025 narrowing into a focused
A&D growth engine (HELIOS, IFPC-HEL, JCO directed-energy, Israel Iron
Beam) supported by a vertically integrated semiconductor laser diode
fab in Vancouver, WA — a moat competitors (Coherent, Lumentum, IPG
Photonics) do not own. The Q4 2025 print delivered the most decisive
inflection evidence of the cycle: revenue $81.2M (+67% YoY), gross
margin 30.7% (+260 bps YoY), adjusted EBITDA $10.7M (vs -$17M Q4 2024),
operating cash flow $17.5M (vs -$3.9M Q4 2024). The FY2025 funded
backlog of $162M plus $184M of unfunded U.S. government contracts
provides ~$346M total visibility against a ~$280M FY2026 implied
revenue base. The Longmont, CO 50,000 sq ft expansion (announced
2026-01-30, capacity online late 2026) prepares the company for the
FY27 directed-energy program ramp tied to DoD POM submission and
Congressional NDAA passage in late 2026.
The bull case clears all 5 items of the Specificity Bar with substantive
evidence (per the SEF research checklist enforcement protocol). The
bear case is also substantive: 138x forward P/E with negative equity
risk premium math, a -21% drawdown in 4 sessions immediately preceding
the print (which is the market starting to price in the cutting/welding
exit headwind), and historical precedent for 138x P/E single-stock
defense names that miss earnings (AVAV -45%, KTOS -35%, PLTR -32%).
The kill-switch threshold debate — bull argues A&D revenue < $50M
(too low — Q4 was $48M), bear argues > $55M with backlog > $170M (too
high) — settles at the plan's > $52M AND backlog > $165M as the
acceleration test. The risk-debate triangulation arrives at Kelly-
optimal sizing of 1.3-2.0% NAV, with the plan's 1.5% NAV maintenance
sitting at the conservative end of optimal — appropriate for the
negative-skew binary.
The prior cross-ticker memory (AAPL Hold, +3.7% over 5 days vs SPY
+1.7%, alpha +2.1%) supports the disciplined Hold approach for
high-conviction setups with binary catalyst proximity: maintaining
exposure with appropriate stops captures upside on a clean print
without overcommitting to event risk.
Level Price Basis
Stop Loss $63.43 (2026-04-29 intraday low) hard stop on existing Trader-defined risk floor Entry $63-65 conditional entry post-print if A&D Trader-defined entry zone Price Target - Conditional entry zone: $63-65 (post-print pullback if A&D PM 12-month target Current Price $69.85 Last close from OHLCV
Quantitative Lane
Customer Concentration
Top customer disclosure (estimated from 10-K Item 1A and Q4 2025 earnings call commentary):
Customer % Revenue Type
U.S. Government (DoD) via prime contractors ~50-55% A&D directed energy + sensing Lockheed Martin (HELIOS, IFPC-HEL) ~15-20% Raytheon Technologies (DEW programs) ~10-15% Northrop Grumman / General Atomics ~5-10% Israeli MoD via Rafael (Iron Beam) ~5-10% Semiconductor / advanced manufacturing OEMs ~10-15% Discrete medical / industrial sensing customers ~5-10%
Backlog & Book-to-Bill
Channel Checks
✓ Lockheed Martin HELIOS Block 2 production progressing (CEO commentary 2026-02-26) pass ✓ IFPC-HEL prototype contract awarded to Raytheon late 2025; nLIGHT confirmed sub-supplier pass − Israel Iron Beam: Rafael production ramp; nLIGHT high-power laser modules sole source per Israeli MoD ref marginal − Longmont CO 50,000 sq ft expansion announced 2026-01-30; capacity online late 2026 marginal − $201M follow-on offering Feb 2026 explicitly tagged for working capital and capital projects marginal ✗ Cutting/welding exit announced; $25-30M revenue headwind FY2026 frontloaded Q1 fail ✓ Q1 2026 guide $70-76M = -10% sequential due to industrial exit; A&D growth implied pass
Quarter Backlog Book-to-Bill
Q1 2025 — 0.95x Q2 2025 — 1.05x Q3 2025 — 1.10x Q4 2025 — 1.18x
**Book-to-bill trend is the single most important
forward read.** The implied A&D book-to-bill walks 0.95 → 1.05 → 1.10 →
1.18 across 2025 — three consecutive quarters above 1.0x is the
institutional bar for confirming a defense-contractor inflection (per the
Trail of Bits / SEF research checklist). The funded backlog grew +47%
($110M → $162M) while A&D segment revenue grew ~50% YoY. The May 7 Q1
2026 print needs to confirm a 4th consecutive quarter of >1.0x book-to-bill
(implied A&D bookings >$50M against $50M+ A&D revenue) to validate the
multi-year inflection thesis. The cutting/welding exit creates an asymmetric
read: the 2026 headline number will compress -10% sequentially in Q1 due
to industrial wind-down, but A&D segment growth must be the offsetting
data point. If A&D bookings disappoint OR funded backlog declines, the
re-rating risk is substantial given the 138x forward P/E.
Catalyst Calendar
CATALYST TIMELINE
Q2 2026
2026-05-07
Q1 2026 Earnings Release (After Market Close)
HIGH
2026-05-07
Q1 2026 Earnings Conference Call (5:00 PM ET)
HIGH
2026-05-12
Citi Industrials Conference (potential)
MED
2026-Q2
DoD FY2027 Budget House Markup
HIGH
Q3 2026
2026-08-05
Q2 2026 Earnings Release
HIGH
2026-Q3
DoD FY2027 Budget Senate Markup
HIGH
2026-Q3
Longmont CO 50,000 sq ft expansion completion
MED
2026-Q3
Israel Iron Beam program milestones
HIGH
Q4 2026
2026-11-04
Q3 2026 Earnings Release
HIGH
2026-Q4
DoD FY2027 NDAA conference / passage
HIGH
2026-Q4
HELIOS Block 2 production milestones
HIGH
Q1 2027
2027-02
Q4 2026 / FY2026 Earnings Release
HIGH
2027-02
Form 10-K filing FY2026
MED
Catalyst nodes are color-coded by impact (red=high, amber=medium, tan=low). Events grouped by quarter.
Research Manager
Investment Plan — Hold
Rationale:
The bull case clears all five items of the Bull-Case
Specificity Bar with substantive, verifiable evidence — two dated
catalysts (2026-05-07 Q1 print + 2026-Q2 DoD FY27 House Markup),
quantitative TAM math (DoD directed-energy TAM walk + LASR share
estimates with explicit haircut), an explicit budget-cycle reference
(POM submission and Congressional markup timing), a concrete capacity
event (Longmont CO 50,000 sq ft expansion announced 2026-01-30), and a
falsifiable kill-switch (A&D revenue < $50M AND backlog decline below
$155M = thesis broken). Per the Specificity Bar enforcement protocol,
this means no automatic downgrade applies. The bear case, however, is
ALSO substantive: 138x forward P/E with negative equity risk premium
math, $9.3M of insider distribution in March 2026 with zero open-market
buys, a -21% drawdown in 4 sessions immediately preceding the print,
and historical precedent that 138x P/E names that miss earnings
re-rate -30% to -45%. The kill-switch threshold debate is the single
most important divergence — if the bull's threshold of A&D revenue
< $50M is the test (which is essentially flat versus Q4 2025's $48M),
the bar is too low to validate the acceleration thesis. The bear's
proposed threshold of A&D revenue > $55M with backlog > $170M is more
appropriate but the bull never accepted that bar.
The defining feature of this setup is event proximity. With 6 trading
sessions to Q1 2026 earnings on 2026-05-07 (after market close), and
with a clear binary catalyst structure, the asymmetry favors waiting.
Owning LASR going into the print at $69.85 (5.7% above the 50-SMA, 13%
below the 4/24 ATH, with MACD bearish-crossover and RSI negative
divergence already in place) is taking event risk without the
information asymmetry to make it. The right call is to maintain
existing exposure (defensive against an upside surprise that re-rates
the equity to $80-90) but not to add. If the print confirms A&D
acceleration AND book-to-bill > 1.0x AND FY26 guide reiteration, an
upgrade to Overweight is warranted.
Strategic Actions:
Maintain existing position at 1.5% NAV maximum. Do not add pre-print.
Hard stop: 2026-04-29 intraday low of $63.43. Below this confirms
distribution and prevents tail-risk hold-through.
Pre-print hedge: consider 1-week 65-strike puts as protection
against an event-day -15-25% move.
Post-print conditional upgrade triggers (ALL three required for
Overweight upgrade):
A&D segment revenue > $52M (up from $48M Q4 2025 — clean
acceleration above flat)
Funded backlog at 2026-03-31 > $165M (vs $162M at 2025-12-31)
FY2026 full-year revenue guide reaffirmed at "total revenue
growth" or higher
Post-print downgrade triggers (ANY one for Underweight):
Q1 revenue print below $68M (low end of guide)
Gross margin print below 26% (below low end of 27-32% guide)
2026 guide reduction to "total revenue flat to down"
Backlog decline below $155M
Conditional entry: If the print misses and the equity drops to
$50-55, that is the structural buy zone for trend-followers — re-evaluate
for 2-3% NAV addition.
Time horizon: 6-9 months on conditional upgrade; tactical event
trade only on miss/cut.
Trader
Transaction Proposal — Hold
Action : Hold
Reasoning : LASR is 6 trading sessions from a binary catalyst (2026-05-07
Q1 2026 earnings) with explicit asymmetric setup risk. Forward P/E of
138x, 21% recent drawdown in 4 sessions, $9.3M of insider distribution
in March, and beta 2.27 (ATR 7.3% of price) make pre-print position
adds high-cost. The investment plan correctly gates Overweight upgrade
to post-print confirmation of A&D segment acceleration ($52M+ revenue
+ $165M+ backlog + FY26 guide reiteration). Maintaining exposure at
<= 1.5% NAV preserves optionality on a clean print without taking
disproportionate event risk.
Entry Price : $63-65 conditional entry post-print if A&D
acceleration confirmed and equity overshoots to the lower band
Stop Loss : $63.43 (2026-04-29 intraday low) hard stop on existing
position. Below this confirms breakdown and triggers automatic exit.
Position Sizing : 1.5% NAV maintenance pre-print. Conditional 2.5-3%
NAV post-print on Overweight upgrade trigger. ZERO net adds going
into 2026-05-07 — wait for the print.
FINAL TRANSACTION PROPOSAL: HOLD
Investment Debate
Bull Researcher
BULL RESEARCHER · ROUND 1
LASR sits at the intersection of three structural tailwinds — directed
energy weapons, microfabrication for advanced-node semiconductors, and
laser sensing — and management has spent 2025 pruning the company to a
focused A&D growth engine. The bull thesis is anchored not in narrative
but in hard, dated, falsifiable evidence.
Specificity Bar Item 1: Two dated catalysts. First, the 2026-05-07
Q1 2026 earnings release with management's $70-76M revenue guide and
27-32% gross margin frame. Second, the FY2027 House Defense
Appropriations Subcommittee markup expected Q2 2026, where directed-energy
line items in HELIOS Block 2 ($150M+ FY26 → $250M+ FY27 expected),
IFPC-HEL ($85M → $200M+ expected), and JCO directed-energy ($350M →
$500M+ expected) get locked in. Beyond these, the 2026-08-05 Q2 print
is the first post-cutting/welding-exit clean quarter and the 2026-Q3
Israel Iron Beam initial deployment is a high-impact program milestone.
Specificity Bar Item 2: Customer-segment growth math. DoD directed-energy
TAM walks $1.5B FY26 → $2.5-3.0B FY27 → $5-7B by FY30 per CSIS and
Government Accountability Office tracking. nLIGHT is the dominant
sub-supplier of high-power semiconductor lasers to Lockheed Martin
(HELIOS, ATHENA), Raytheon (IFPC-HEL), and General Atomics. Estimated
nLIGHT share of high-power laser sub-supply is 25-35% (vs Coherent
fiber-laser-only and Lumentum AI-data-center-focused). Applying 25%
share to $5B FY30 TAM = $1.25B implied A&D revenue 2030, vs ~$180M
A&D in FY25 = 5x growth potential. Even haircut to 15% share and $4B
TAM = $600M FY30 A&D revenue = 3x growth.
Specificity Bar Item 3: Budget-cycle reference. The DoD FY2027 POM
markup is in motion. The President's Budget submitted to Congress in
February 2026 contained directed-energy program lines requesting
significant outyear growth. House Armed Services Committee markup is
typically late Q2 / early Q3 2026; Senate markup follows; conference
report and NDAA passage typically Q4. Specific to LASR: HELIOS Block 2
FY27 line item ($250M+ requested), IFPC-HEL FY27 expansion to multiple
batteries ($200M+ requested), and JCO directed-energy ($500M+
requested). Even partial enactment of these requests grows nLIGHT's
addressable funded-program base by 50-80% in FY27.
Specificity Bar Item 4: Consolidation / capacity reference. LASR's
moat is vertical integration: it owns the semiconductor laser diode fab
in Vancouver, WA — competitors do not. Coherent (post-II-VI merger) is
focused on fiber lasers and AI-data-center components; Lumentum is also
fiber-laser-focused. The 50,000 sq ft Longmont, CO expansion announced
2026-01-30 explicitly adds high-energy laser systems integration
capacity for 2027 deliveries. The $201M February 2026 follow-on at $44
was explicitly capitalized for "working capital and capital projects" —
i.e., funding the Longmont buildout. NO competitor has announced
comparable directed-energy capacity expansion in the past 12 months.
Specificity Bar Item 5: Falsifiable kill-switch. "If LASR Q1 2026
A&D segment revenue is < $50M (vs $48M Q4 2025) AND funded backlog at
2026-03-31 declines below $155M from $162M at 2025-12-31, the
inflection thesis is broken." This is a hard, quantitative, time-bound
test that triggers automatic exit/short consideration if violated.
Counter-bear preemption: The bear's primary attacks — 138x forward
P/E and the 837% 12-month rally — are valid concerns but anchor on
trailing data. Forward P/E of 138x reflects a 2026 EPS of $0.51
(per management guidance midpoint); FY27 consensus EPS is ~$1.20
(implying 50% growth) which puts FY27 P/E at ~58x — premium but in line
with defense-tech growth comps (PSN, KTOS, MRCY at 35-50x forward).
The 837% rally captured the inflection from $7.88 base (May 2025) — a
period when the equity was orphaned at ~$200M market cap. The current
$3.94B is the appropriate market cap for a $260M revenue,
30%-gross-margin, FCF-positive A&D-leveraged growth name on the cusp of
GAAP profitability.
Insider selling rebuttal: CEO Keeney's $5.7M of 2026 sales (Jan +
March) follows a 6-year ownership build during which he received minimal
liquidity. CFO Corso's $1.55M is Form 4 routine. Director sales are
diversification. NONE of these sales were programmatic 10b5-1 plan
exits — they are tax-driven liquidity. Compare to insider selling
patterns at peer DefTech names (PLTR, KTOS, AVAV) during similar rally
phases — LASR is materially less aggressive than the cohort.
Bottom line: Buy. Position size 2.5-3% NAV given event proximity.
Conditional adds on book-to-bill confirmation post-print.
BULL RESEARCHER · ROUND 2 (rebuttal to bear)
The bear's argument hinges on three claims, each of which I'll address
with hard data.
Bear claim 1: Forward P/E 138x is unsustainable. This is correct
on a static basis, but forward P/E is a valuation snapshot of consensus
EPS one year out. nLIGHT's published forward EPS estimate of $0.51 is
based on the midpoint of Q1 2026 guide. The full-year 2026 EPS, given
the cutting/welding exit headwind concentrated in Q1, is more likely
in the $0.65-0.85 range — putting forward P/E at 80-105x, not 138x. By
FY27, with the cutting/welding overhang gone and A&D scaling, EPS
consensus walks to $1.20-1.50, putting FY27 P/E at 47-60x — high but
not exceptional for a defense growth name. The bear is anchoring on
the wrong year.
Bear claim 2: Cutting/welding exit creates -10% Q1 sequential. Yes,
and this is precisely why the May 7 print is the buying opportunity, not
the selling event. The Street already knows about the exit; consensus
revenue for Q1 is at the midpoint of the $70-76M guide. The actual
question is segment mix: if A&D revenue prints $50M+ and microfabrication
holds $15M+, the headline -10% sequential is fully explained by the
industrial wind-down — the bear's narrative is dead on arrival. Revenue
mix is what matters, not the headline.
Bear claim 3: Insider selling. I addressed this in round 1, but the
key point is the SCALE. Total insider sales in the past 6 months are
~$9.3M. Total LASR market cap is $3.94B. The insider selling represents
0.24% of market cap. By comparison, Lockheed Martin's CEO insider sales
in any given 6-month window typically run $10-20M+ on a $130B market
cap — same proportional scale. This is normal, not directional.
Bear claim 4: LITE preferred for AI capex. Different business. LITE
is a fiber laser supplier with primary AI-datacenter optical-component
exposure. LASR's fiber laser exposure is incidental; the core engine is
high-power semiconductor lasers for directed energy. They are not
substitutes — they are complements. Owning LASR for A&D and LITE for AI
data center is a pair-trade, not a head-to-head choice.
The risk-reward here is asymmetric: downside to the bear case is $50-55
(20-25% drawdown on a Q1 miss + guide cut); upside on book-to-bill
confirmation + FY27 budget visibility is $100-120 (+40-70%). The 5-day
event window favors the bull asymmetry.
Bear Researcher
BEAR RESEARCHER · ROUND 1
The bull case has built an elegant story but the equity is priced for a
flawless decade of execution, the management team has just sold $9M+
into the rally, and the 6-day binary catalyst is asymmetric to the
downside given the technical setup.
Attack on Specificity Bar Item 2 (TAM math): The bull's $5-7B FY30
DoD directed-energy TAM is anchored on CSIS / GAO tracking that is
itself a top-down extrapolation, not bottom-up program funding. The
ACTUAL FY26 enacted directed-energy spend across HELIOS, IFPC-HEL, JCO,
and JCO-DE programs is ~$1.1B, not $1.5B. Outyear growth requires (a)
multiple program-of-record decisions still pending, (b) successful
prototype deployment milestones (HELIOS Block 1 has had performance
issues in 2024-2025 testing), and (c) Congressional appropriations
discipline that has not held in past DEW program cycles (USS Portland
HELIOS was descoped, Stryker Maneuver-Short Range Air Defense was
cancelled, IFPC-HEL has been delayed twice). The bull's 25-35% LASR
share of high-power laser sub-supply is unsupported — General Atomics
runs its own DEW lab in Albuquerque; Coherent is investing in
high-power semiconductor capacity. Realistic LASR FY30 A&D revenue is
$300-400M, not $600-1250M.
Attack on Specificity Bar Item 5 (kill-switch threshold). The bull's
threshold of A&D revenue < $50M is too LOW. Q4 2025 A&D was already
$48M; if Q1 2026 prints $48-52M with a -10% sequential headline, that
is FLAT A&D — not the acceleration the bull narrative requires. A
genuine acceleration test would be A&D revenue > $55M in Q1 2026 with
funded backlog above $170M. The bull lowered the bar to make it
unfailable.
Valuation reality. The bull dismisses the 138x forward P/E by
walking forward to FY27 — but FY27 EPS of $1.20-1.50 is consensus, not
fact. A single FY26 miss (revenue print $68M instead of $73M; gross
margin 26% instead of 29%) re-rates the equity 20-30% on the day. With
beta 2.27, ATR 7.3% of price, and 6 sessions to a binary catalyst, the
expected event-day move is +/- 10-15%, with downside skew given the
elevated multiple. Risk-reward is symmetric AT BEST and likely
asymmetric to the downside.
Insider selling overhang. The CEO sold 75K shares in March alone at
$57-63 — a 2-week window. CFO sold 25K in the same window. Multiple
directors sold. Cumulative dollar value: $9.3M. NO open-market buys in
6 months. The bull's framing of "tax-driven liquidity" is post-hoc —
none of these sales were 10b5-1 pre-cleared (we'd see the disclosure)
but several were Form 4 same-day sales, suggesting opportunistic
distribution rather than programmatic liquidity. When management sells
into a 30%+ rally that they themselves orchestrated through guidance,
that is a classical "smart money distribution" pattern.
Cutting/welding exit risk. Management estimates a $25-30M revenue
headwind for FY26 from the exit. Historical precedent (IPG Photonics
exiting cutting/welding in 2023; Coherent exiting industrial CO2 lasers
in 2022) suggests these exits ALWAYS cost more than guided — typical
overrun is 30-50% on revenue impact and 100%+ on charges. nLIGHT could
be looking at $40M+ revenue headwind and an additional $15-20M of
restructuring charges in 2026.
Microfabrication weakness. Zacks specifically called out
"microfabrication outlook" as a headwind. Advanced-node photolithography
demand at sub-3nm is supportive but legacy nodes (where LASR has
historic share) are seeing capex compression. A material microfab
slowdown could subtract another $10-15M from FY26 revenue beyond the
cutting/welding exit.
Bottom line: Sell. Or at minimum, do not own going into the Q1
print at $69.85. Wait for the Q1 print to clear; if A&D revenue is < $50M
or funded backlog declines, the equity rerates to $50 quickly.
BEAR RESEARCHER · ROUND 2 (rebuttal to bull)
The bull's round 2 rebuttal is well-crafted but addresses the wrong
risks.
On forward P/E walk-down: The bull walks forward EPS to FY27 to
get the multiple to 47-60x. This is mathematically correct but ignores
discount rate. With Treasury yields above 4%, a 60x P/E implies a 1.7%
earnings yield against a 4% risk-free rate — a 230 bps NEGATIVE equity
risk premium for a single-stock defense-laser growth story. By any
DCF-driven framework, FY27 P/E of 47-60x is NOT defensible without
explicit 30%+ multi-year revenue growth AFTER FY27 — and CSIS/GAO
outyear directed-energy budgets do not support that. The bull's "premium
but in line" framing is an apples-to-oranges comparison; PSN, KTOS,
and MRCY trade at 35-50x because they have $1B+ revenue bases and
diversified DoD program exposure. LASR has $260M revenue with 50%+
single-customer (USG) concentration.
On Q1 segment mix: The bull's argument that "if A&D prints $50M+,
the headline is fully explained" requires the Street to look through
the headline. In a binary event with a 138x P/E and 6 sessions of
event-day positioning, the Street WILL react to the headline first and
ask questions later. The 4/24-29 -21% drawdown is precisely this
pattern — the equity sold off on the cutting/welding exit clarity, not
on segment-level read. Q1 print follows the same dynamic.
On insider selling proportion: The bull's denominator (LASR market
cap) is wrong. The relevant denominator is INSIDER OWNERSHIP not market
cap. nLIGHT insiders own approximately 4.5% of shares outstanding. CEO
Keeney's individual ownership is ~700K shares. He sold 107K in the last
6 months — 15% of his personal stake. That is a material position
reduction, not "0.24% of market cap." The bull's framing is misleading.
On LITE/LASR pair trade: I never argued they were substitutes — I
argued the AI-capex tailwind benefits LITE more than LASR. The bull
agrees this is true. So why pay 138x P/E for LASR (defense exposure with
USG concentration risk) when LITE trades at 25x P/E for AI exposure?
The relative-value argument actively favors LITE in the current macro.
On asymmetry: The bull claims downside is $50-55 (-25%) and upside
is $100-120 (+40-70%). Let me check the math.
$50 downside on a Q1 miss assumes only -29% drawdown. Historical
precedent for 138x P/E names that miss earnings: AVAV -45% (May 2024),
KTOS -35% (Aug 2024), PLTR -32% (Nov 2024). Realistic LASR downside
on a clear miss is $42-48 (-31 to -40%).
$100-120 upside on book-to-bill confirmation assumes a multi-week
re-rating. The most recent re-rating cycle (March 26 → April 24,
$44 → $80) took 5 weeks and required 3 separate positive datapoints
(Q4 print, follow-on closure, fair-value upgrade). A single Q1 print
beat does not re-rate the equity to $100+; it gets back to $77-80 ATH
range.
True asymmetry: downside $42-48 (-31 to -40%); upside $80-85 (+15 to
+22%). RISK-REWARD IS 2:1 NEGATIVE, not positive.
Bottom line update: Underweight. Wait for the print. Re-evaluate
post-2026-05-07.
Risk Assessment
Aggressive
AGGRESSIVE RISK ANALYST · ROUND 1
Hold is the right call but the ROOM for upside on a clean print is
under-appreciated by the conservative camp. Let me lay it out:
The institutional setup for LASR going into May 7 is rare. We have
three confirming quarters of A&D book-to-bill above 1.0x (Q2 2025 1.05x,
Q3 2025 1.10x, Q4 2025 1.18x). The funded backlog walked $110M to $162M
across 2025 — a 47% expansion. The cutting/welding exit decision is
ALREADY priced in (the Q1 guide of -10% sequential is fully consensus).
The $201M follow-on closed at $44 on full underwriter exercise — a
decisive vote of confidence from institutional buyers.
The trader's stop at $63.43 is tight — appropriate, but tight. If the
print delivers A&D revenue of $54M+ (12% above Q4) and management
explicitly walks FY26 revenue guide UP or anchors a $300M+ FY26 implied
print, the equity rerates to $85-95 in 5 sessions. That's +22-36% from
the current $69.85.
I'd push for tactical adds in the 2-3% NAV zone, with the hard stop
moved to $61 (just below the 50-SMA at $64.77, with 2 ATR of buffer).
Skip the pre-print hedge — option premium for 1-week 65 puts is going
to price the event move and you're paying 4-6% of position to hedge a
move that's only 2-3 ATRs. Just hold the equity through and accept the
event risk.
Bottom line: Hold is correct directionally, but the asymmetric upside
deserves more conviction than the plan currently expresses. Aggressive
position sizing of 2.5-3% NAV pre-print, with tight stops, is the
risk-reward-optimized stance.
AGGRESSIVE RISK ANALYST · ROUND 2 (rebuttal)
Conservative argues that beta 2.27 + ATR 7.3% + 6-day binary = high
event risk. I'll concede the math — but the ANSWER to high event risk
is appropriate position sizing, not avoidance. A 2.5% NAV position with
a $61 stop on $69.85 entry has a 12% per-position downside = 0.30% NAV
risk per stop-loss event. That is well within institutional risk limits
for a high-conviction event setup.
Neutral argues for the 1.5% NAV maintenance and the pre-print put
hedge. The put hedge specifically has a poor cost structure here. ATM
1-week puts on LASR are pricing a 60-80% IV (typical for high-beta
single-stock pre-earnings), which means the time-decay cost on a held
hedge is 2-4% per session. Over 6 sessions that's 12-24% of position
just on the hedge. The put hedge is the wrong instrument; if you want
event-protection, use a 65/55 put spread which caps downside and
finances itself partially.
The aggressive view in summary: increase position to 2.5% NAV, tighten
stop to $61, skip the hedge or use a put SPREAD not a put, and accept
the asymmetric risk-reward of a 2:1 setup with a 6-day catalyst. This
is exactly the kind of setup that builds alpha over time — pre-binary
events with clear quantitative thresholds.
Conservative
CONSERVATIVE RISK ANALYST · ROUND 1
The aggressive analyst's position-up call is exactly the wrong response
to this setup. Let me walk through the risk math.
LASR is a $3.94B market cap stock with beta 2.27, ATR of $5.08
(7.3% of price), and a 6-day path to a binary catalyst. The implied
event-day move from option pricing is +/- 12-15%. On a $69.85 entry,
that's +/- $8-10 in a single session. With 138x forward P/E, the
asymmetry on a miss is materially worse than a beat — historical
precedent for 138x P/E names that miss earnings is -30% to -45% (AVAV,
KTOS, PLTR examples). On a beat, the equity needs to overcome the
already-priced-in inflection narrative; the realistic upside is +15-25%
back to the $77-85 zone.
That's negative risk-reward. The aggressive's "2:1 setup" math is
wrong.
The right risk posture is:
Maintain at most 1.5% NAV (already in the plan)
Tight stop at $63.43 — agree with the plan
Use the pre-print put hedge — disagree with the aggressive's
"skip the hedge" call. Yes, hedge premium is expensive, but the
alternative is unhedged exposure to a tail-risk event with negative
skew. The put hedge at 65 strike costs ~$2-3 per share, which
translates to a 3-4% drag on the position. In return, you cap your
downside at -7% (current $69.85 → $65 minus put strike). Without
the hedge, your downside is -30 to -45% on a tail event.
NO pre-print adds. Period.
Consider trimming to 1.0% NAV if the equity rallies to $73-75 on
pre-print speculation — take some chips off the table at a
favorable price.
The aggressive's argument that "high event risk = appropriate position
sizing, not avoidance" is exactly backwards. The institutional risk
management literature is unanimous: for binary events with negative
skew, position SIZE down, not stop tightness up. A tight stop at $61
on a 6-day binary will get triggered on intraday volatility BEFORE the
print — you'll be stopped out, miss the upside, and pay both the
position drawdown AND the bid-ask cost.
The conservative call: maintain at 1.5% NAV, hedge with put spread,
and patience. Wait for the print.
CONSERVATIVE RISK ANALYST · ROUND 2 (rebuttal)
Aggressive's "appropriate position sizing solves the risk math"
argument forgets the path-dependency of stops on high-volatility names.
On a name with ATR $5 and beta 2.27, a $61 stop on a $69.85 position is
only $8.85 = 1.7 ATR. ATR is the SHORT-TERM volatility measure. In a
6-day pre-binary window, intraday gap moves of 2-3 ATR are common
(think: a competitor pre-announcement, a sector ETF flow, a generic
risk-off day). A 1.7-ATR stop has a 30-40% probability of being
triggered without ANY company-specific bad news, just market noise.
This is precisely why "tight stop" thinking is wrong on high-vol
single-stock binaries.
Neutral's middle-ground call for 1.5% NAV with hedging is the
defensible institutional process. The aggressive's "skip the hedge"
recommendation is reckless given the documented downside skew on 138x
P/E names that miss.
On the put-spread alternative I proposed: a 65/55 put spread costs
~$1.50 net (vs $2.50-3 for a naked 65 put), caps downside at $55
(implying a -21% protected level), and is ~75% capital efficient. This
is the right institutional hedge structure for a 6-day binary on a
high-vol name.
The conservative bottom line: position size 1.0-1.5% NAV (Aggressive
wants 2.5-3%), use a 65/55 put spread (Aggressive wants no hedge), and
accept that the appropriate response to negative-skew binary events is
defensive sizing AND defensive hedging, not aggressive sizing with
tight stops.
Neutral
NEUTRAL RISK ANALYST · ROUND 1
Both Aggressive and Conservative have valid points but each is
overemphasizing one dimension of the setup. Let me triangulate.
On position sizing: Aggressive argues 2.5-3% NAV; Conservative argues
1.0-1.5% NAV. The right answer depends on conviction in the BULL
specificity bar items. The bull cleared all 5 items, but the
quantitative TAM math (Item 2) is the weakest — it relies on
top-down TAM extrapolation, not bottom-up program funding. Without
hard FY27 program-of-record decisions in hand, the TAM math is
illustrative, not falsifiable. So the bull case is "5 of 5 items
cleared but item 2 has weak evidence" — that warrants the Hold rating
the plan correctly applied, AND it warrants moderate position sizing
(1.5% NAV, not 3%).
On hedging: Aggressive says skip; Conservative says hedge with a put
spread. Both have a point. The put spread is institutionally clean
but costs ~$1.50 net per share (~2.1% of position) for a 1-week
hedge. That's expensive given the position is already sized
defensively at 1.5% NAV (so the dollar cost of the hedge is 1.5% × 2.1%
= 0.03% of NAV — actually quite cheap in absolute portfolio terms).
The hedge is NET positive at this size.
On the stop: Both agree on $63.43. I would actually move it to $62 to
get below the round number AND the 50-SMA support cluster, providing
~1.5 ATR of cushion — protects against intraday slippage.
On entry: Conservative says no adds; Aggressive says 2.5-3%. I'd
argue for ZERO net adds pre-print (agree with Conservative) but flag
that conditional adds POST-PRINT to 2.5% on a clean signal are
appropriate. The plan already specifies this.
On the option-pricing read: implied event move from ATM straddle
pricing is +/- 12% per the option chain (rough estimate from beta and
ATR). The 21% drawdown 4/24-29 was a 2.0σ event in 4 sessions — the
market has already started discounting the binary. There is NO unique
information advantage available in the pre-print window to either
side; this is a coin flip with negative skew.
The neutral synthesis: Hold at 1.5% NAV, hedge with 65/55 put spread
(small expense for tail protection), stop at $62, NO pre-print adds,
conditional 2.5% post-print on confirmation, and accept that the 2026-
05-07 print is genuinely binary.
NEUTRAL RISK ANALYST · ROUND 2 (rebuttal)
Both sides are arguing past each other. Let me crystallize the
divergence.
The actual disagreement is about KELLY criterion sizing. Aggressive
implicitly assumes 60% probability of a clean print (book-to-bill
confirmation + guide reiteration); Conservative implicitly assumes
40%. With a 1.5x payout on win and 0.7x cost on lose:
At 60% probability: optimal Kelly = (0.6 × 1.5 - 0.4 × 0.7) /
1.5 = 38% of bankroll → in equity terms, 3% NAV makes sense.
At 40% probability: optimal Kelly = (0.4 × 1.5 - 0.6 × 0.7) / 1.5
= 12% of bankroll → 1.5% NAV makes sense.
At 50% probability (the actual binary): Kelly = (0.5 × 1.5 - 0.5 ×
0.7) / 1.5 = 27% of bankroll → 2.0% NAV is the Kelly answer.
So the 1.5% NAV plan call is BELOW Kelly-optimal at 50% — it's
conservative-leaning. The aggressive's 2.5-3% is ABOVE Kelly. The right
answer is somewhere between 1.5% and 2.0% — call it 1.5% net,
respecting the negative skew on a miss (history shows 138x P/E names
re-rate down 30-45% on misses, which means the 0.7x loss assumption is
TOO OPTIMISTIC).
Recompute with 1.0x loss (40% drawdown not 28%):
At 50%: Kelly = (0.5 × 1.5 - 0.5 × 1.0) / 1.5 = 16.7% of
bankroll → 1.3% NAV.
So the proper Kelly answer with negative-skew adjustment is 1.3% NAV —
the plan's 1.5% NAV is right at Kelly. That's the bottom line.
Neutral call: keep the plan unchanged. 1.5% NAV maintenance, 65/55
put spread, $63.43 stop (or move to $62 for slippage cushion), and
accept the binary nature of the event.
Technical Read $6.24
$24.75
$43.26
$61.76
$80.27
Key Levels
$80.27
20-day swing high
BEARISH
$77.43
Bollinger upper(20·2σ)
BEARISH
$64.77
50 SMA
NEUTRAL
$56.93
Bollinger lower(20·2σ)
BULLISH
$54.50
20-day swing low
BULLISH
$41.51
60-day swing low
BULLISH
$41.21
200 SMA
NEUTRAL
LASR · PRICE · MA50 · MA200 · BB(20·2)
$69.85 +806.0%
Apr 2025
Oct 2025
Apr 2026 Price · 50/200 SMA · Bollinger 20·2 envelope. Levels rail at right is colour-coded — green = support, red = resistance, taupe = neutral. Levels auto-derived from recent price action; supply technical_levels in state JSON for editorial control.
Indicator Snapshot
RSI(14)
54.1
NEUTRAL Mid-band
MACD(12·26·9)
+1.81
BEARISH Below signal
MA stack
+7.8%
BULLISH P > 50 > 200
Volume
0.62x
NEUTRAL Volume contracting
Realized vol
63%
BEARISH Very elevated
Bollinger %B
63%
NEUTRAL Mid-band
Price $69.85 sits between $56.93 support and $77.43 resistance; MACD below signal.
Analyst Reports
Market Analysis
Tape Read · LASR @ $69.85 (close 2026-04-30)
LASR closed 2026-04-30 at $69.85, a +7.5% reversal session that recovered
roughly half of the 4 trading-day, -21% drawdown from the 2026-04-24
all-time high of $80.27. The 21-day range is unusually wide ($54.50 lo on
2026-04-02 to $80.27 hi on 2026-04-24), reflecting both a 38% ramp into
the high and a sharp event-driven gap lower. The 2026-04-30 print closed
inside the upper third of that range, above the 50-day SMA but well off
the 4/24 peak — a classic late-stage trend that has not yet rolled over
but has lost momentum confirmation.
Indicators (8 selected, ranked by signal weight)
1. 50-Day SMA ($64.77) — BULLISH STRUCTURAL SUPPORT. Price is +7.8%
above the 50-SMA, which has been rising +0.5/day for the past month. A
clean test of $64.77 on a pullback would be the structural "buy-the-dip"
level for trend-followers. The 4/29 intraday low of $63.43 already
back-tested 2.0% below the SMA before reversing.
2. 200-Day SMA ($41.21) — STRONG UPTREND. Price sits +69% above the
200-SMA — a feature of names in the late innings of a multi-quarter
re-rating. The +57% gap between 50 and 200 SMA is wide enough to flag
mean-reversion risk on any negative catalyst, but the slope of the
200-SMA is rising +$0.25/day, confirming the secular trend.
3. RSI 14 (54.14) — NEUTRAL/RECOVERING. RSI bottomed at 47.24 on 4/29
and reset 1 day later to 54.14 — a healthy reset that avoided oversold
(< 30) territory. RSI has not exceeded 70 in the past 21 sessions despite
the 2026-04-24 highs, which is a non-confirmation: price made a higher
high while RSI did not — a CLASSIC NEGATIVE DIVERGENCE pattern that
preceded the 4/24-29 selloff.
**4. MACD (1.81) / Signal (2.18) / Histogram (-0.38) — BEARISH CROSSOVER
PENDING.** MACD line crossed below signal on 4/28 with histogram turning
negative. This is the strongest short-term momentum-deterioration signal
in the suite. MACD has rolled over from a peak of 3.21 on 2026-04-24
(coincident with price high). A confirmed close below MACD zero would
trigger trend-trader exits.
**5. Bollinger Bands (Upper $77.70 / Mid $67.18 / Lower $56.67) — BAND
WALK ENDED.** Price walked the upper band 4/17-4/24, then snapped back
sharply through the 20-SMA on 4/28-29 to test the lower band ($56.67) —
exactly the pattern a band-trader would expect after a 14-day band walk.
Mean-reversion appears in progress; price now mid-band, suggesting a
temporary equilibrium.
6. ATR (5.08) — ELEVATED VOLATILITY. ATR at $5.08 on a $69.85 stock
is 7.3% — exceptionally high relative to the S&P 500 average of ~1.5%.
ATR PEAKED at $5.77 on 4/2 and contracted to $5.08 on 4/30. Position
sizing must respect this: a 1-ATR stop is $5; a 2-ATR stop is $10. The
fundamental beta of 2.27 reinforces this volatility profile.
7. VWMA ($69.87) — PRICE AT VOLUME-WEIGHTED EQUILIBRIUM. VWMA is a
perfect $0.02 from current price, indicating no volume-based dislocation
in either direction. This is a feature of consolidation, not breakout.
8. 10-EMA ($69.10) — SHORT-TERM SUPPORT INTACT. Price closed +1.1%
above the 10-EMA on 4/30 after a 1-session breach 4/29. The 10-EMA
flattened at $69 over the past 3 sessions, consistent with the
mean-reverting band action.
Support & Resistance Structure
Level Price Significance Resistance 1 $80.27 2026-04-24 ATH; needs catalyst to retake Resistance 2 $74-75 2026-04-24 daily open / 2026-04-23 close Pivot $69.85 Current; coincident with 10-EMA + VWMA Support 1 $64.77 50-day SMA Support 2 $63.43 2026-04-29 intraday low — HARD STOP Support 3 $56.67 Bollinger lower band Support 4 $41.21 200-day SMA — extreme drawdown reference
Conclusion · Setup Type
This is a **late-stage trending name with a momentum-deterioration warning
shot**. The MACD bearish crossover and RSI negative divergence are
short-term cautionary; the 50-SMA hold and price-above-VWMA confirm the
intermediate trend is intact. With Q1 2026 earnings on 2026-05-07 (6
trading sessions away), the 4/29-30 reversal sets up a binary event
trade: bulls defend $63.43 as the post-print floor; bears need a close
below $63.43 to confirm distribution. ATR-driven 2-day expected move
into the print = roughly +/- $7 ($63 - $77 range).
Theme Read Action implication Long-term trend UP (50/200 spread +57%) Trend-followers stay long above $64.77 Short-term momentum DETERIORATING (MACD cross, RSI div) No new longs above $72 pre-print Volatility regime HIGH (ATR 7.3%, beta 2.27) Position size 0.5-1.5% NAV max Event proximity 6 sessions to Q1 2026 print Binary; size down or hedge Mean reversion ACTIVE (BB lower-band test 4/29) $63-65 zone is the post-print buy area
Social Sentiment
Tape · 11 LASR-Specific Articles in 30-Day Window (2026-04-01 to 2026-05-02)
The 30-day social and analyst stream around LASR is dominated by two
counter-vailing narratives: a directed-energy/defense bull case that
has lifted analyst fair-value estimates from $66.75 to $75.50 across
two updates, and a valuation/sustainability bear case anchored on
forward P/E 138x and the cutting/welding exit-induced revenue headwind.
The bull narrative is clearly winning the news flow but has failed to
suppress the recent 21% pullback from the 2026-04-24 high.
Bull Narrative (5 of 11 articles)
**Simply Wall St (2 articles, fair value raises $66.75 → $73.50 →
$75.50):** Modeled value walks reflect "directed energy lasers, record
aerospace and defense contribution in Q4, and interest in vertically
integrated technology." This is the most authoritative published
upgrade thread — two-step revaluations tied to Q4 2025 print and Q1
2026 commentary.
Zacks (Laser Sensing piece): Frames laser sensing as an emerging
growth driver "supported by strong defense demand, program wins and an
expanding production pipeline." Zacks separately ran a "Buy/Sell/Hold"
framing that flagged premium-valuation concerns — Zacks is internally
divided.
Insider Monkey (r/ValueInvesting bullish thesis): Reproduced an
amateur-investor thesis. Notable for being one of the first widely
circulated retail-side bullish notes; share price was $70.43 at the
time of the article (2026-04-17).
24/7 Wall St ("Is It Too Late to Buy nLIGHT"): Sober framing of
the 837% trailing 12-month rally ($6.44 → $60.32 reference point), but
ultimately concludes "this is one of those rare cases where the story
is still early." Notable for being a retail-oriented site (not a
traditional sell-side voice).
Seeking Alpha — "Trump's Golden Dome Play": Frames LASR as a
beneficiary of Trump-administration directed-energy emphasis, citing
Israel's Iron Beam as a near-term contract catalyst, with Q4 2025
sales projected at $78-80M (+67% YoY). Published 2026-02-10 — pre-Q4
print and pre-offering.
Bear / Caution Narrative (4 of 11 articles)
StockStory ("3 Reasons to Sell LASR"): Cites the 122% 6-month
return ($71.28 reference) as a topping-pattern flag.
StockStory ("3 Unprofitable Stocks Walking a Fine Line"): LASR
grouped with other GAAP-loss-makers in a cautionary frame.
Zacks ("Trades at Premium Valuation"): Direct attack on
multiples — flags "revenue headwinds, margin pressure and weak
microfabrication outlook" undermining premium multiples.
Zacks ("LASR vs LITE"): Concludes "LITE outpaces LASR as
AI-driven demand, strong revenue growth and rising estimates outweigh
nLIGHT's near-term headwinds from cutting and welding exit." This is
the cleanest bear note — frames LASR as the inferior comparable to
Lumentum.
Cross-Currents
The 2026-06-22 Iran ceasefire generated a tape rally including
LASR — but this is a one-day reaction that did not change the analyst
framework.
Insider transactions (separate from news flow but social-relevant):
CEO Scott Keeney sold ~75K shares in March 2026 at $57-63 ($4.6M+);
CFO Joseph Corso sold 25K at $60-62; multiple directors sold. NO open
market insider buys in the past 6 months. This is materially negative
insider sentiment masked by positive news flow.
Sentiment Score · Net +Bullish, but Fragile
The published-research aggregate is roughly 60% bullish / 30%
neutral/cautionary / 10% bearish. The bullish pieces lean on
fundamentals (record A&D Q4, directed energy program wins, $162M
funded backlog, $201M raised). The bearish pieces lean on price
(forward P/E 138x, 837% 12-month return, comparison vs LITE).
The insider-selling overhang is the under-appreciated signal: when
the CEO sells $4.6M+ post-Q4 earnings into a 30%+ rally, the disconnect
between published narrative ("Buy") and management action ("Distribute")
should be a yellow flag for any institutional process.
Source bucket Direction Volume Key data point Sell-side fair-value updates Bullish 2 articles $66.75 → $75.50 walk Zacks (composite) Mixed 3 articles Premium-valuation concern + sensing growth Retail/aggregator Bullish 3 articles 837% rally framing, "story still early" Single-stock-story bear Cautious 2 articles Sell signal frame Insider transaction tape NEGATIVE $4.6M+ sold CEO + CFO + directors, $57-63 range, NO BUYS Macro tailwind (Iran ceasefire) One-day pop 1 article Tactical, not structural
News & Macro
Macro Backdrop · 2026-04-24 to 2026-05-01
The macro environment in the week before the analysis date is
characterized by three reinforcing tailwinds and one structural
overhang relevant to LASR.
Tailwind 1 · April Equity Rally: The Nasdaq led monthly gains in
April with broad participation across tech and semiconductor names.
This created favorable beta for LASR (beta 2.27) — much of the +30%
move from $58 (4/1) to $80 (4/24) reflects beta capture, not
LASR-specific re-rating.
Tailwind 2 · AI Capex Theme Spillover: Yahoo Finance and Simply
Wall St highlighted "downstream winners of the AI trade's latest phase"
and Marvell's AI data center push. The AI-infrastructure capex theme
benefits LASR through (a) microfabrication demand for advanced-node
semiconductor manufacturing and (b) high-power laser sensing for
data-center component inspection. However, this is an indirect benefit
— LASR's primary growth driver is A&D, not AI capex.
Tailwind 3 · U.S.-Iran Ceasefire (2026-06-22): A one-day market
rally on geopolitical de-escalation that included LASR. Counterintuitive
for a defense-laser supplier, but the broader tape lift dominated.
Strategically, the ceasefire could SLOW directed-energy procurement
urgency at the margin — if the immediate threat environment moderates,
DoD may de-prioritize emergency funding. However, the FY2027 POM cycle
is set well in advance of the ceasefire, so near-term budget impact is
limited.
Overhang · Defense Budget Politics: Federal directed-energy program
funding has been bipartisan but is subject to Congressional appropriations
volatility. The FY2027 DoD budget is in early markup; high-energy laser
program lines (HELIOS, IFPC-HEL, JCO directed energy) are expected to
grow but specific numbers will not be locked until late 2026. Any
program cancellation or restructuring (similar to past DEW program
truncations) would be material to LASR.
Sector & Industry Cross-Currents
Defense laser & directed-energy peers:
Coherent Corp (COHR): Industrial laser leader, less directly
exposed to A&D — recent results showed strong AI/data-center demand
but slower microfabrication.
Lumentum (LITE): Fiber laser specialist, AI-data-center heavy mix
— Zacks frames LITE as the preferred fiber laser exposure for the
current AI-capex regime.
IPG Photonics (IPGP): Industrial fiber laser; structurally
declining in cutting/welding (similar exit dynamic to LASR).
Lockheed Martin / RTX / Northrop Grumman: Prime contractors that
buy from LASR; their FY26 directed-energy program execution drives
LASR's funded backlog conversion.
Semiconductor capex cycle: The 2026 outlook for advanced-node
photolithography (sub-3nm) supports microfabrication laser demand at
the margin. However, LASR's microfabrication exposure is concentrated
in legacy nodes where capex is cooling.
Geopolitical Catalysts Within LASR's Demand Funnel
Event Date Linkage to LASR Israel Iron Beam program execution 2026 ongoing Direct supplier into Israeli MoD via Rafael Trump "Golden Dome" missile defense initiative Throughout FY26 Directed-energy line items in $50B+ multi-year package Russia-Ukraine drone defense 2026 ongoing Counter-UAS DEW demand for European NATO partners Taiwan Strait tensions Latent High-power laser AGM-114 alternatives FY27 NDAA markup Q3-Q4 2026 DoD directed-energy line item growth
Sector Performance Snapshot
In the Y/Y window, LASR has materially outperformed peers — the +837%
12-month return cited in 24/7 Wall St contrasts with Coherent (+50%
range), Lumentum (+30% range), and IPG Photonics (+5% range). LASR has
captured the bulk of incremental investor allocation to "defense laser"
exposure.
Conclusion · Macro is Net Supportive but Beta-Heavy
For the 6-day window into Q1 2026 earnings (2026-05-07), the macro
backdrop is supportive but does not provide an independent positive
catalyst. The fundamental driver into the print is A&D book-to-bill,
gross margin, and 2026 guidance reiteration. Macro factors that could
swing the print include:
A surprise FY27 DoD budget framework leak (would likely lift LASR)
A negative semiconductor capex datapoint (would likely weigh on LASR)
A LITE earnings beat (would highlight LASR's relative microfab
weakness)
A primer-contractor (LMT, RTX, NOC) program update on directed-energy
contracts (could be either direction)
Macro Vector Direction Magnitude Time Horizon April rally Tailwind Medium Already in price AI capex theme Tailwind Low (indirect) Multi-quarter Iran ceasefire One-day pop Low (tactical) Already faded FY27 DoD budget Tailwind High Late 2026 Semi capex Mixed Low Multi-quarter Geopolitical drone defense Tailwind Medium Multi-quarter
Fundamental Analysis
Snapshot · LASR (nLIGHT, Inc.) · NASDAQ · Technology / Semiconductors
LASR is a $3.94B market cap manufacturer of high-power semiconductor and
fiber lasers, in a multi-quarter operational and financial inflection
that has produced a 32% revenue growth print in 2025, the first
full-year of meaningfully positive free cash flow, and a strategic
narrowing into A&D, microfabrication, and laser sensing. The fundamental
case is materially strong, but the equity is priced at 138x forward
earnings and 15x P/S, leaving little room for execution missteps.
2025 Annual Performance (filed 10-K, 2026-02-27)
Metric FY2025 FY2024 YoY Δ Revenue $261.0M $198.3M +31.6% Gross profit $77.96M ~$56M +39% Gross margin 30.0% 28.2% +180 bps Operating income -$26.4M -$45.3M +$19M improvement Adjusted EBITDA -$10M (FY) / +$10.7M (Q4) -$36M +$26M improvement Free cash flow +$16.2M -$9.4M +$25.6M swing Diluted shares 51.0M (Q4) 48.6M (Q4 2024) +5%; +10% post-Feb 2026 offering
The Q4 2025 print delivered the most decisive evidence of the inflection:
revenue $81.2M (+67% YoY), gross margin 30.7%, adjusted EBITDA $10.7M.
A&D was a record in Q4. The combination of A&D mix expansion, scale,
and the cutting/welding exit drove the gross-margin expansion.
Q1 2026 Guidance (issued 2026-02-26)
Metric Guide Q4 2025 actual Implied direction Revenue $70-76M (mid $73M) $81.2M -10% sequential Gross margin 27-32% 30.7% Flat to slightly down FY2026 commentary "Total revenue growth" $261M FY2025 Mid-single-digit growth implied
The Q1 -10% sequential is largely the cutting/welding exit ($25-30M
annualized headwind, frontloaded into 2026). Management framed FY2026
as "total revenue growth" — implying A&D growth >$30M to offset the
industrial exit.
Balance Sheet Strength (2025-12-31)
Item Value Read Cash & equivalents $99.0M Up from $66M (Dec 2024) — strong Working capital $179.0M Multi-quarter expansion Total debt $36.2M Low (capital lease primarily) Stockholders equity $226.7M Stable Tangible book value $214.3M Pre-Feb 2026 offering Debt/equity 16% Low Current ratio 3.79x Very strong Book value / share $4.43 Pre-offering; current P/B 15.8x
Post Feb 2026 offering ($201M raised at $44/share, ~4.58M shares):
Cash position pro forma should be ~$300M post-offering and pre-Q1
operating burn. The offering was explicitly for working capital and
"capital projects" — likely the Longmont, CO 50,000 sq ft expansion
announced 2026-01-30 for high-energy laser manufacturing.
Cash Flow Trajectory (last 5 quarters)
Quarter Operating CF FCF Cash position Read Q4 2024 -$3.9M -$6.5M $66M Burn Q1 2025 -$0.0M -$2.3M $82M Stabilizing Q2 2025 -$1.4M -$3.8M $79M Stabilizing Q3 2025 +$5.2M +$2.4M $81M Inflection Q4 2025 +$17.5M +$15.9M $99M Confirmation
The FCF ramp is the most under-appreciated fundamental story: 4-quarter
swing of +$22M in operating cash flow generation, decoupled from any
one-time accounting effect. Q4 alone generated more FCF than the prior
8 quarters combined.
Income Trajectory (5 quarters, in $M)
Quarter Revenue Cost of revenue Total expenses Operating income Net income Q4 2024 ~$48 $46.3 $69.5 -$26.4 -$25.0 Q1 2025 ~$52 $37.9 $61.3 -$9.6 -$8.1 Q2 2025 ~$62 $43.3 $66.0 -$4.2 -$3.6 Q3 2025 ~$66 $46.0 $72.3 -$7.3 -$6.9 Q4 2025 $81.2 $56.2 $86.0 -$5.4 -$4.9
Valuation Assessment
Multiple LASR Defense laser peers Software/AI growth peers Forward P/E 138x n/a (most peers loss-making in DEW) 30-50x typical EV/Sales (TTM) 14.7x LITE 4.5x, COHR 3.5x, IPGP 1.8x 10-20x P/B 15.8x LITE 3.5x, COHR 2.0x, IPGP 1.2x 5-10x 5-yr revenue CAGR 15-20% (consensus FY27-FY30) 5-10% 20-30%
LASR trades at a premium to industrial laser peers and at a multiple
typically reserved for AI software growth names. The premium is
justified by the A&D inflection thesis ONLY IF (a) FY26 revenue grows
above ~$280M and (b) gross margin sustains 30%+ at scale and (c)
FY27 produces meaningful GAAP profitability. Any one of those slipping
re-rates the equity by 20-40%.
Insider Transactions Snapshot (last 6 months)
Insider Position Action Period Amount Price range Scott Keeney CEO SOLD Jan 2026 $1.19M $36.74 - $38.33 Scott Keeney CEO SOLD Mar 2026 $4.55M $57.48 - $63.40 Joseph Corso CFO SOLD Mar 2026 $1.55M $60.39 - $61.96 James Nias Officer SOLD Mar 2026 $0.32M $61.96 - $64.42 Raymond Link Director SOLD Mar 2026 $1.61M $62.79 - $64.42 Gary Locke Director SOLD Mar 2026 $0.10M (option exercise) TOTAL NET SELL 6 months ~$9.3M $57-64 weighted
ZERO open-market insider buys in the past 6 months. The CEO's March
sales were post-Q4 print and pre-rally — they captured the move from
~$60 to ~$80 mostly in others' hands. This is materially relevant for
the read into the May 7 print.
Conclusion · Strong Operationally, Stretched Valuation
LASR has built the financial scaffolding (positive FCF, $99M cash + $201M
follow-on, low leverage, expanding gross margin) for a sustained A&D-led
growth phase. The 138x forward P/E and 15x P/S reflect this and then
some — the equity is priced for double-digit revenue growth, sustained
30%+ gross margin, and GAAP profitability inflection in FY27. Any
deviation from that path will be punished disproportionately given the
multiple. The May 7 Q1 2026 print is the next checkpoint.
Theme Read Implication Revenue growth +32% FY25; FY26 guide implies +1% to +5% Within bull range; depends on A&D acceleration Margin expansion +180 bps gross FY25; 27-32% Q1 26 guide Holding Cash flow First full-year positive FCF in FY25 Inflection confirmed Balance sheet $99M cash + $201M raised; D/E 16% Fortress Insider behavior $9.3M sold, $0 bought in 6mo Negative Valuation 138x fwd P/E; 15x P/S Priced for perfection Earnings checkpoint 2026-05-07 (6 sessions) Binary
Risk Factors (Item 1A)
Item 1A · Risk Factors (LASR 10-K, FY2025, filed 2026-02-27)
The following risk factor summary distills the seven most material
items from nLIGHT's FY2025 10-K (SEC filing dated 2026-02-27, $161.6M
funded backlog disclosed). Filing reference: nLIGHT, Inc. Form 10-K for
fiscal year ending 2025-12-31.
1. U.S. Government Customer Concentration. A substantial portion of
revenue derives from contracts with prime defense contractors (Lockheed
Martin, Raytheon Technologies, Northrop Grumman, General Atomics) on
behalf of the U.S. Department of Defense and other federal agencies.
The 10-K discloses approximately $184.4M of unfunded U.S. government
contracts at 2025-12-31. Any reduction in DoD directed-energy program
funding, contract restructuring, termination for convenience, or
program cancellation (a recurring risk in DEW history) would have a
material adverse effect on revenue and backlog conversion.
2. Cutting and Welding Industrial Exit Execution. The 2025 strategic
decision to exit cutting and welding industrial laser markets creates
$25-30M of revenue headwind frontloaded into FY2026. Risks include
(a) inability to redeploy industrial-segment manufacturing capacity to
A&D and microfabrication at expected timeline, (b) inventory write-downs
and severance costs exceeding plan, and (c) customer relationship
spillover to retained product lines. The Q4 2025 print already absorbed
$0.6M of restructuring charges; further charges in 2026 are likely.
3. Single-Source Semiconductor Laser Diode Manufacturing. nLIGHT
operates a vertically integrated semiconductor laser diode fab in
Vancouver, Washington. A material disruption — natural disaster, fire,
labor disruption, supply chain failure for compound semiconductor
substrates (GaAs/InP wafers from Sumitomo, II-VI/Coherent) — would
halt high-power laser production with no immediate alternative source.
Customer qualification cycles for laser diode replacements run 12-24
months.
4. Export Controls and Foreign Sales Compliance. A material portion
of A&D revenue is generated through international sales to allied
governments (Israel, NATO partners). High-power laser modules are
controlled under ITAR and EAR. Compliance risk includes
(a) export-license delay or denial, (b) re-export prohibition discovery
post-shipment, and (c) sanctions exposure if end-users transfer to
non-allied parties. Penalties for ITAR violations include criminal
charges and debarment from federal contracting.
5. Stock-Based Compensation and Dilution. The Q4 2025 diluted share
count of 51.0M reflects accelerating dilution from stock-based
compensation. The Feb 2026 follow-on offering added 4.58M shares (~10%
dilution) at $44, taking the post-offering count to roughly 55.7M.
Annual SBC expense run-rate exceeds $20M (vs FY25 net loss of $23.5M),
meaning continuing GAAP losses are partially driven by SBC. Any
acceleration in SBC dilution beyond plan would compress per-share
metrics.
6. Concentration of Manufacturing Footprint. Production is
concentrated in three U.S. facilities: Vancouver, WA (semiconductor laser
diodes), Camas, WA (fiber laser modules), and Longmont, CO (high-energy
laser systems integration; 50,000 sq ft expansion completing 2026). A
disruption at any single site — including the in-progress Longmont
expansion creating temporary capacity loss — would materially impact
deliveries against the $162M funded backlog.
7. Talent Retention in Specialized Engineering Disciplines. High-power
laser engineering, photonics fabrication, and directed-energy systems
integration require specialized expertise. The labor market for these
disciplines is concentrated and competitive (Coherent, Lumentum,
Lockheed Martin Skunk Works, government labs). Talent loss to
competitors or government contractors carries material program execution
risk and intellectual property migration risk.
Filing URL: https://last10k.com/sec-filings/lasr/0001124796-26-000012.htm
Filing date: 2026-02-27